Sökning: WFRF:(Eeg Olofsson Karin) >
Evaluation of cost-...
Evaluation of cost-utility in middle ear implantation in the 'Nordic School' : a multicenter study in Sweden and Norway
-
- Edfeldt, Lennart (författare)
- Uppsala universitet,Öron-, näs- och halssjukdomar,University of Uppsala Hospital, Sweden
-
- Strömback, Karin (författare)
- Uppsala universitet,Öron-, näs- och halssjukdomar,University of Uppsala Hospital, Sweden
-
- Grendin, Joakim (författare)
- Umeå universitet,Medicinska fakulteten,ENT Clinic,Umeå University Hospital, Sweden
-
visa fler...
-
- Bunne, Marie (författare)
- Oslo University Hospital, Norway
-
- Harder, Henrik (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för neurovetenskap,Hälsouniversitetet,Öron- näsa- och halskliniken US
-
- Peebo, Markus (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för neurovetenskap,Hälsouniversitetet,Öron- näsa- och halskliniken US
-
- Eeg-Olofsson, Mans (författare)
- Sahlgrens University Hospital, Sweden
-
- Petersson, Carl-Magnus (författare)
- Skåne University Hospital, Sweden
-
- Konradsson, Konrad (författare)
- Uppsala universitet,Öron-, näs- och halssjukdomar,University of Uppsala Hospital, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2013-11-21
- 2014
- Engelska.
-
Ingår i: Acta Oto-Laryngologica. - : Informa UK Limited. - 0001-6489 .- 1651-2251. ; 134:1, s. 19-25
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Conclusion: Hearing restoration using an active middle ear implant (AMEI) is a highly cost-effective treatment for a selected group of patients with no other possibilities for auditory rehabilitation. Objectives: To evaluate the cost-utility of using an AMEI for hearing rehabilitation. Methods: This was a prospective, multicenter, single-subject repeated study in six tertiary referral centers. Twenty-four patients with sensorineural (SNHL), conductive (CHL), and mixed hearing loss (MHL) were implanted with the AMEI Vibrant Soundbridge (R) (VSB) for medical reasons. All patients were previously rehabilitated with conventional hearing aids. Multiple validated quality of life patient questionnaires, Health Utilities Index (HUI 2 and 3), and Glasgow Hearing Aid Benefit Profile (GHABP) were used to determine the utility gain and quality adjusted life years (QALY). Directly related treatment costs for the implantation were calculated and related to utility gain and QALY. Results: The cost/QALY for patients with SNHL was estimated at (sic)7260/QALY, and for patients with C/MHL at (sic)12 503/QALY.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kirurgi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Surgery (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- Active middle ear implant
- sensorineural hearing loss
- conductive and mixed hearing loss
- quality of life
- MEDICINE
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas